Intellectual Property

  • August 14, 2026

    Bad Bunny Says Judge Made Bad Call On Reggaeton IP Suit

    Attorneys for Bad Bunny and other artists Friday asked a California federal judge to reconsider his order denying their clients an early win in a sprawling copyright case over the origin of reggaeton music, saying the plaintiffs stitched together parts of multiple songs to argue they have a protectable, copyrighted work.

  • August 14, 2026

    Corteva To Pay $3.1M In Ark. AG's Pesticides Antitrust Suit

    Corteva has agreed to pay $3.1 million to settle the Arkansas attorney general's antitrust suit accusing the pesticide maker of using anticompetitive rebates that amount to exclusive agreements to suppress generics competition, according to a preliminary approval motion filed in federal court on Thursday.

  • August 14, 2026

    Cubs, Nationals Say WNBA's 'The W' TM Bid Risks Confusion

    The Chicago Cubs and Washington Nationals have teamed up to oppose the WNBA's bid to register "The W" for apparel, telling the Trademark Trial and Appeal Board that the league's proposed mark is likely to be confused with the baseball clubs' longstanding "W" trademarks.

  • August 14, 2026

    ITC Revives Juul Case Against Altria, Scrubs Invalidity Ruling

    The U.S. International Trade Commission vacated an administrative law judge's determination that a Juul vape patent was invalid, reviving the company's case against Altria's NJOY business because of a claim construction issue.

  • August 14, 2026

    ITC Fights Bid To Force Baby Carrier Co. To Drop Case

    The U.S. International Trade Commission told an Idaho federal court that it should reject a baby carrier manufacturer's request that a judge force a rival litigant to withdraw its parallel complaint before the ITC.

  • August 14, 2026

    USPTO Wants Input On Southwest Outreach Office

    The U.S. Patent and Trademark Office is looking to increase its community outreach in the Southwest and is asking for public input on where it should set up offices in the six-state region.

  • August 14, 2026

    Nielsen Loses At Fed. Circ., Fights Verdict In Patent Row

    The Nielsen Co. Friday lost its attempt at the Federal Circuit to revive claims of a patent it accused TVision Insights Inc. of infringing, as it fights a jury verdict clearing TVision of infringing a separate patent.

  • August 14, 2026

    OpenAI Fights Sanctions Bid In News Copyright MDL

    OpenAI on Friday urged a New York federal judge to reject sanctions that could bar it from relying on a 20 million-chat evidence sample in copyright litigation brought by The New York Times and other news organizations, arguing it did not violate a preservation order or misrepresent its ability to search for copyrighted material.

  • August 14, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen newly signed Real Madrid footballer Yan Diomandé sued over access to his image rights, Nigel Farage and Reform UK deputy leader Richard Tice accuse the NCA of leaking confidential financial information, and a right-wing American journalist hit The Guardian with a libel claim. 

  • August 13, 2026

    Serena Williams Loses Bid To Register 'Serena Ventures' TM

    The Trademark Trial and Appeal Board has denied tennis star Serena Williams a trademark registration for the phrase "Serena Ventures" for her venture capital business, saying it's likely to be confused with an existing registration for "Serena" that covers overlapping services.

  • August 13, 2026

    Netlist Targets Micron, HPE After Huge Samsung IP Deal

    Netlist Inc. has filed a new U.S. International Trade Commission complaint accusing Micron and three other companies of infringing multiple memory patents with their imports, less than two weeks after the patent owner announced a nearly $1 billion licensing deal with Samsung over the same technology.

  • August 13, 2026

    Baker Botts Atty Cleared Of Defamation In Inventor's Suit

    A Florida federal judge on Thursday tossed a defamation claim against a Baker Botts LLP patent attorney after agreeing with a magistrate judge's conclusion that an inventor had not shown that the lawyer's comments to a reporter were defamatory.

  • August 13, 2026

    J&J Says No To Reviving Stelara Case

    Johnson & Johnson has asked the Fourth Circuit not to revive CareFirst's antitrust suit alleging the company tried to monopolize the market for the immunosuppressive drug Stelara.

  • August 13, 2026

    Large Cos., Foreign Filers Winning At USPTO, Report Finds

    The U.S. Patent and Trademark Office has been leaving independent inventors behind with patent grants, instead favoring large corporations based in the U.S. and abroad, according to a new report from Labrynth.

  • August 13, 2026

    4th Circ. Won't Undo Block Of Gilead-Branded Drug Imports

    The Fourth Circuit on Thursday refused to undo a lower court's order in a trademark suit that blocked a vendor, used by health plans to cut medication costs, from importing Gilead-branded medications into the U.S.

  • August 13, 2026

    Nike Agrees To End Appeal Of TM Fee Award At 3rd Circ.

    Clothing-maker Lontex Corp. and Nike Inc. have agreed to put an end to their battle over a lower court's finding that the sportswear giant had to pay attorney fees in a trademark case, asking the Third Circuit to undo a decision that the case was exceptional.

  • August 13, 2026

    3rd Circ. Upholds Dismissal Of Lipitor Pay-To-Delay Case

    The Third Circuit on Thursday backed the dismissal of an antitrust suit alleging Pfizer Inc. and Ranbaxy Laboratories Ltd. conspired to delay the market entry of a generic version of the cholesterol drug Lipitor, ruling that the plaintiffs lacked standing.

  • August 13, 2026

    Judge Declines To Boot Shoe Accessory Copyright Suit

    A Pennsylvania federal judge has refused to toss a copyright lawsuit filed by a sneaker crease protector company against a competitor, finding that the allegations were "on solid footing" except for one defendant.

  • August 13, 2026

    Lilly Claims 6 Vendors Illegally Sold Obesity Drug Candidate

    Eli Lilly & Co. hit a medical spa business, compounding pharmacy and a group of chemical suppliers with claims they're illegally selling an obesity drug candidate Lilly is researching, telling California and Texas federal courts the alleged "black market" sales threaten public health.

  • August 13, 2026

    NC Biz Court Bulletin: Judges Retire, HCA Suit Heads To Trial

    The North Carolina Business Court dropped a host of heavy-hitting opinions in July ahead of two judicial retirements and a new chief judge rising in the ranks.

  • August 12, 2026

    ITC Judge Finds Asus Infringed Netgear Wi-Fi Patent Claims

    An administrative law judge for the U.S. International Trade Commission made an initial finding that Taiwanese electronics manufacturer Asus and another Wi-Fi device seller infringed claims in a couple of patents licensed to Netgear. 

  • August 12, 2026

    Disney, Warner Fight AI Co.'s Bid To Trim Copyright Case

    Disney, Warner Bros. and NBCUniversal urged a California federal court on Wednesday to reject Midjourney's bid to narrow their copyright lawsuit, arguing the artificial intelligence company is misreading the U.S. Supreme Court's March ruling limiting secondary copyright liability for internet service providers and that the decision does not foreclose claims of intentionally promoting infringement.

  • August 12, 2026

    Spotify Urges Permanent Toss Of Rapper's Bot-Streaming Suit

    A rapper alleging that Spotify allows fraudulent bots to manipulate streaming data once again failed to show how his commercial association with the platform ascends to a "special relationship" under California law, Spotify said in a motion to permanently dismiss the amended complaint filed Tuesday.

  • August 12, 2026

    Squires Tells Fed. Circ. PTAB Made Error In Corteva Decision

    U.S. Patent and Trademark Office Director John Squires has asked the Federal Circuit to intervene in Inari Agriculture's appeal of a Patent Trial and Appeal Board decision upholding a Corteva patent on insect-repellent corn, saying part of the board's decision was wrong.

  • August 12, 2026

    She Has A Point: Shutts & Bowen's Jodi-Ann Tillman

    Jodi-Ann Tillman of Shutts & Bowen LLP was brought into patent infringement litigation over drum technology just months before trial, and her performance earned high praise from opposing counsel, Foley & Lardner LLP partner Laura Ganoza.

Expert Analysis

  • A Shift In Fed. Circ.'s Approach To Patent Summary Judgment

    Author Photo

    The Federal Circuit's recent decision in Range of Motion v. Armaid may come to be seen as a seminal opinion for potentially exposing and entrenching the Federal Circuit's movement away from its previous framework for identifying obvious noninfringement cases, says Nicholas Nowak at Nowak IP Group.

  • Considering The Risks That Arise When IP Outlives Its Owner

    Author Photo

    Federal and state court decisions show that the statutory regime for each category of intellectual property promises continuity after the owner's death, but the law does not provide a succession framework for how those rights are to be exercised, says Erin Daly at Daly Law & Strategy.

  • How A High Court Music Piracy Ruling Shrinks ISP Liability

    Author Photo

    The U.S. Supreme Court's recent opinion in Cox Communications Inc. v. Sony Music Entertainment, which concerned the boundaries of contributory copyright infringement for internet service providers, dramatically lessens both the risk that an ISP will be held contributorily liable and, relatedly, the incentives an ISP may have to help combat online copyright infringement, say attorneys at Debevoise.

  • Opinion

    AI Presents A Make-Or-Break Moment For Outside Counsel

    Author Photo

    The rapid adoption of artificial intelligence by corporate legal departments is forcing a long-overdue reset of the relationship between inside and outside counsel, and introducing a significant opportunity to shed frustrating inefficiencies and strengthen collaboration for firms willing to embrace the shift, says Intel Chief Legal Officer April Miller Boise.

  • Opinion

    USPTO Has A Chance To Correct Double-Patenting Doctrine

    Author Photo

    Now that the issue of obviousness-type double patenting is front and center before the U.S. Patent and Trademark Office's Appeals Review Panel, the agency should put an end to the practice of rejecting earlier-expiring patents in favor of later-expiring ones, say attorneys at Orrick.

  • 1st AI Acquisition Regulation Raises Contractor Concerns

    Author Photo

    The General Services Administration’s recently published contract clause addressing artificial intelligence systems is problematic in a number of ways, underscoring the complex legal and practical issues that will need to be addressed as AI becomes more widely deployed in federal contracting, say attorneys at Haynes Boone.

  • Grammarly Suit Flags Right Of Publicity As Key AI Issue

    Author Photo

    Angwin v. Superhuman Platform, filed recently in New York federal court against the parent company of Grammarly, highlights an overlooked question for any company using artificial intelligence — whether someone's identity has been used for commercial purposes without consent, possibly violating rapidly shifting state right-of-publicity laws, says Nicholas Schneider at Eckert Seamans.

  • Series

    Watching Hallmark Movies Makes Me A Better Lawyer

    Author Photo

    I realize you may be judging me for watching, and actually enjoying, Hallmark Channel movies, but the escapism and storylines actually demonstrate qualities and actions that lead to an efficient, productive and positive legal practice, says Karen Ross at Tucker Ellis.

  • Reel Justice: 'Mercy' And Private Surveillance As Evidence

    Author Photo

    The near-future depicted in the film “Mercy” reminds attorneys that private surveillance networks are becoming central to the evidentiary ecosystem, shaping what prosecutors can obtain, what defendants must explain and what jurors may interpret as objective truth, says Veronica Finkelstein at Wilmington University.

  • Fed. Circ. In February: When Grammar Trumps Patent Specs

    Author Photo

    The Federal Circuit's decision in Netflix v. DivX last month highlights the challenge of interpreting potentially misplaced modifiers in complicated technological patents, and the potential for grammatical rules to provide a default interpretation for unclear claim language, say attorneys at Knobbe Martens.

  • New Orphan Drug Law Provides A Key Fix For Pharma Cos.

    Author Photo

    The Consolidated Appropriations Act enacted last month restores the U.S. Food and Drug Administration's long-standing interpretation of "same disease or condition," related to orphan drug exclusivity, resolving years of regulatory uncertainty and litigation that have discouraged rare disease research, say attorneys at Spencer Fane.

  • When Trade Secret Litigation And Criminal Law Collide

    Author Photo

    An increasing convergence of trade secret litigation and white collar defense, especially with several recent criminal prosecutions from the Justice Department, should prompt businesses and counsel to adapt within the overlapping landscapes, says Kenneth Notter at MoloLamken.

  • Opinion

    PTAB Needs Reform To Protect Inventors From Larger Cos.

    Author Photo

    The Promoting and Respecting Economically Vital American Innovation Leadership Act is necessary because it will impose additional requirements on patent validity challenges and prevent large corporations from taking advantage of the Patent Trial and Appeal Board to overwhelm small inventors with repeated litigation, says Eb Bright at ExploraMed Development.

  • Changes Coming To The SBIR And STTR Programs

    Author Photo

    Legislation recently approved by Congress to reauthorize the Small Business Innovation Research and Small Business Technology Transfer Programs includes changes focused on national security that would improve transparency but also increase applicants' administrative burdens, slow the awards process and likely increase litigation, say attorneys at Fluet & Associates.

  • Witness AI Usage Is The Next Privilege Battle In Civil Litigation

    Author Photo

    Fact and expert witnesses now have immediate access to artificial intelligence systems capable of simulating deposition questioning, recommending answers and more, but this preparation occurs privately, invisibly and frequently under the mistaken assumption that it is harmless, says Bill Kanasky at Courtroom Sciences and Billy Davis at Taylor Nelson.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.